81 related articles for article (PubMed ID: 25872559)
21. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma.
Wagener R; Alexandrov LB; Montesinos-Rongen M; Schlesner M; Haake A; Drexler HG; Richter J; Bignell GR; McDermott U; Siebert R
Leukemia; 2015 Jul; 29(7):1612-5. PubMed ID: 25650088
[No Abstract] [Full Text] [Related]
22. Role of activation-induced cytidine deaminase in inflammation-associated cancer development.
Marusawa H; Takai A; Chiba T
Adv Immunol; 2011; 111():109-41. PubMed ID: 21970953
[TBL] [Abstract][Full Text] [Related]
23. Gene deletion speeds mutation rate.
Cancer Discov; 2014 Jul; 4(7):754. PubMed ID: 25002600
[TBL] [Abstract][Full Text] [Related]
24. Mediators and dynamics of DNA methylation.
Shoemaker R; Wang W; Zhang K
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):281-98. PubMed ID: 20878927
[TBL] [Abstract][Full Text] [Related]
25. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination.
Besmer E; Market E; Papavasiliou FN
Mol Cell Biol; 2006 Jun; 26(11):4378-85. PubMed ID: 16705187
[TBL] [Abstract][Full Text] [Related]
26. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
[TBL] [Abstract][Full Text] [Related]
27. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
28. Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.
Mori S; Takeuchi T; Ishii Y; Kukimoto I
Biochem Biophys Res Commun; 2015 May; 460(3):555-60. PubMed ID: 25800874
[TBL] [Abstract][Full Text] [Related]
29. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141
[TBL] [Abstract][Full Text] [Related]
30. Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation.
Kühn K; Bertling WM; Emmrich F
Biochem Biophys Res Commun; 1993 Jan; 190(1):1-7. PubMed ID: 8422236
[TBL] [Abstract][Full Text] [Related]
31. Immunology. One AID to unite them all.
Fugmann SD; Schatz DG
Science; 2002 Feb; 295(5558):1244-5. PubMed ID: 11847327
[No Abstract] [Full Text] [Related]
32. Activation-induced deaminase: controversies and open questions.
Barreto VM; Ramiro AR; Nussenzweig MC
Trends Immunol; 2005 Feb; 26(2):90-6. PubMed ID: 15668124
[No Abstract] [Full Text] [Related]
33. [Role of minor histocompatibility antigens in hematopoietic cell transplantation].
Akatsuka Y
Rinsho Ketsueki; 2006 Oct; 47(10):1353-63. PubMed ID: 17094574
[No Abstract] [Full Text] [Related]
34. Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.
Bogerd HP; Kornepati AV; Marshall JB; Kennedy EM; Cullen BR
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7249-56. PubMed ID: 26668372
[TBL] [Abstract][Full Text] [Related]
35. Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.
Caval V; Suspène R; Vartanian JP; Wain-Hobson S
Mol Biol Evol; 2014 Feb; 31(2):330-40. PubMed ID: 24162735
[TBL] [Abstract][Full Text] [Related]
36. Poisoning Cancer Cells with Oxidized Nucleosides.
Helleday T
N Engl J Med; 2015 Oct; 373(16):1570-1. PubMed ID: 26465992
[No Abstract] [Full Text] [Related]
37. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
38. AID and partners: for better and (not) for worse.
Storck S; Aoufouchi S; Weill JC; Reynaud CA
Curr Opin Immunol; 2011 Jun; 23(3):337-44. PubMed ID: 21439803
[TBL] [Abstract][Full Text] [Related]
39. Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
Chaudhuri J; Tian M; Khuong C; Chua K; Pinaud E; Alt FW
Nature; 2003 Apr; 422(6933):726-30. PubMed ID: 12692563
[TBL] [Abstract][Full Text] [Related]
40. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma.
Deng Y; Du Y; Zhang Q; Han X; Cao G
Cancer Lett; 2014 Feb; 343(2):161-71. PubMed ID: 24120759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
